Queue raises $12.6M in Seed

Queue has secured $12.6 million in seed funding to advance its autonomous pharmacy kiosk technology. The financing round, led by AlleyCorp, is part of the company's vision to revolutionize pharmaceutical dispensing through robotic kiosks. These kiosks allow patients to collect medication through a simple QR code verification, aiming to streamline access and reduce wait times.

The newly raised seed funding, alongside $6 million in prior pre-seed investment led by Riot Ventures, brings Queue's total funding to $18.6 million. Other investors include House Capital, Ubiquity Ventures, Grep Ventures, and Banter Capital. Queue's technology currently supports around 280 medications, addressing the problem of limited pharmacy access in remote and underserved areas by providing a faster, more accessible alternative to traditional pharmacies.

Queue's co-founder and CTO, Josh Liu, describes the initiative as a comprehensive reimagining of medication dispensing rather than a mere incremental improvement. The kiosks are positioned as a cost-effective solution, claiming to reduce dispensing costs by 96% compared to conventional pharmacies. Tailored to community needs, each kiosk maintains a curated stock of frequently prescribed medications, managed by AI to ensure timely restocking.

The strategic rationale for Queue's technology is multifaceted. The system not only addresses accessibility issues but also serves as a relief mechanism for existing pharmacy venues struggling with labor shortages. This comes amid a backdrop of significant understaffing in the retail pharmacy sector, with a shortfall in pharmacist graduates exacerbating the strain on the workforce. Queue has already forged an agreement with a major national pharmacy chain and is piloting a prototype to validate market readiness.

As the pharmacy sector continues to incorporate technological advancements, Queue's initiative reflects broader trends towards increased efficiency and patient engagement through AI and automation. With the retail pharmacy market projected to grow substantially, Queue's autonomous kiosks could catalyze further innovation in pharmaceutical logistics.

Queue plans to utilize the new funding to enhance product development and extend its deployment across existing customer networks, targeting a large-scale rollout by early next year. This funding will also support the expansion of its engineering team based in Silicon Valley, preparing the company for broader implementation and potential sector disruptions.